RE: AstraZeneca bets $247M AI can create a cancer-fighting antibody7 Feb 2024 11:17
Read what FAB CEO said
rns 9th Feb 2023, see what happens this February 2024, one year since the original deal was agreed
Fusion Antibodies CEO, Adrian Kinkaid said: "We are delighted to be able to announce the successful development of the Mammalian Display technology, an output from our OptiMAL® research programme. As our industry rapidly turns to find new ways to hasten the development of better bio-therapeutics to the clinic, we also anticipate deploying these capabilities to bring AI generated antibody sequences out of world class computer algorithms and into a world class antibody laboratory."
Fusion Antibodies CEO, Adrian Kinkaid said: "We are delighted to be able to announce the successful development of the Mammalian Display technology, an output from our OptiMAL® research programme. As our industry rapidly turns to find new ways to hasten the development of better bio-therapeutics to the clinic, we also anticipate deploying these capabilities to bring AI generated antibody sequences out of world class computer algorithms and into a world class antibody laboratory."